Immune Pharmaceuticals Inc (fka IMNPQ)

[Letterpenny]

Just so we are clear…..

Effective Date and Transition Provisions

The final rule will become effective 125 days after publication in the Federal Register. Registrants must begin tagging disclosures in Inline XBRL beginning 490 days after publication of the final rule in the Federal Register (i.e., one year after the effective date of the final rule).
Ongoing SPAC and de-SPAC transactions that have not yet been completed will be required to adhere to the new requirements under the final rule once it is effective.